NCT00519233View on ClinicalTrials.gov

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Prostate Cancer

Interventions

DRUG

AGS-1C4D4

IV

Trial Locations (2)

10065

New York

21205

Baltimore

Sponsors

Lead Sponsor

Astellas Pharma Inc

Collaborators (1)

All Listed Sponsors

collaborator

Agensys, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY